Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > new (but not new information) article June 29

<< Previous

Bullboard Posts

Next >>

Comment by tamarindo1on Jun 29, 2021 8:35pm

185 Views

Post# 33470930

RE:new (but not new information) article June 29

DJDawg wrote:

https://www.eurekalert.org/pub_releases/2021-06/uota-ult062921.php

June article. Nothing new but nice to read.

Thanks DJDawg. From the article,

A cancer survivor herself, McFarland said her goal is to provide more treatment options for cancer patients, particularly for those whose cancer is unresponsive to traditional therapies

I did not know that.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment